| Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community A Gupta, R Wood, R Kaplan, LG Bekker, SD Lawn PLoS One 7 (3), e34156, 2012 | 312 | 2012 |
| Doravirine/lamivudine/tenofovir disoproxil fumarate is non-inferior to efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive adults with human … C Orkin, KE Squires, JM Molina, PE Sax, WW Wong, O Sussmann, ... Clinical Infectious Diseases 68 (4), 535-544, 2019 | 193 | 2019 |
| Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has … M Aboud, R Kaplan, J Lombaard, F Zhang, JA Hidalgo, E Mamedova, ... The Lancet infectious diseases 19 (3), 253-264, 2019 | 183 | 2019 |
| Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited C Orrell, G Harling, SD Lawn, R Kaplan, M McNally, LG Bekker, R Wood Antiviral therapy 12 (1), 83-88, 2007 | 177 | 2007 |
| Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. A Boulle, C Orrell, R Kaplan, G Van Cutsem, M McNally, K Hilderbrand, ... International Medical Press, 2007 | 169 | 2007 |
| Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa SD Lawn, F Little, LG Bekker, R Kaplan, E Campbel, C Orrell, R Wood Aids 23 (3), 335-342, 2009 | 168 | 2009 |
| The impact of gender and income on survival and retention in a South African antiretroviral therapy programme M Cornell, L Myer, R Kaplan, LG Bekker, R Wood Tropical Medicine & International Health 14 (7), 722-731, 2009 | 155 | 2009 |
| Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa MD Nglazi, SD Lawn, R Kaplan, K Kranzer, C Orrell, R Wood, LG Bekker JAIDS Journal of Acquired Immune Deficiency Syndromes 56 (1), e1-e8, 2011 | 153 | 2011 |
| Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa MD Nglazi, K Kranzer, P Holele, R Kaplan, D Mark, H Jaspan, SD Lawn, ... BMC infectious diseases 12, 1-7, 2012 | 142 | 2012 |
| Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status R Wood, SD Lawn, J Caldwell, R Kaplan, K Middelkoop, LG Bekker PloS one 6 (10), e25098, 2011 | 134 | 2011 |
| Loss to follow-up and mortality amongst pregnant women referred to a community clinic for antiretroviral treatment R Kaplan, C Orrell, E Zwane, LG Bekker, R Wood AIDS (London, England) 22 (13), 1679, 2008 | 122 | 2008 |
| Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection AR Lifson, B Grund, EM Gardner, R Kaplan, E Denning, N Engen, ... Aids 31 (7), 953-963, 2017 | 106 | 2017 |
| Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa RK Gupta, SD Lawn, LG Bekker, J Caldwell, R Kaplan, R Wood The international journal of tuberculosis and lung disease 17 (8), 1014-1022, 2013 | 87 | 2013 |
| Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa A Gupta, R Wood, R Kaplan, LG Bekker, SD Lawn PloS one 8 (2), e55824, 2013 | 75 | 2013 |
| Rates of switching antiretroviral drugs in a primary care service in South Africa before and after introduction of tenofovir C Njuguna, C Orrell, R Kaplan, LG Bekker, R Wood, SD Lawn PloS one 8 (5), e63596, 2013 | 63 | 2013 |
| Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township SD Lawn, L Campbell, R Kaplan, F Little, C Morrow, R Wood, ... BMC infectious diseases 11, 1-9, 2011 | 58 | 2011 |
| The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a … MD Nglazi, LG Bekker, R Wood, R Kaplan BMC infectious diseases 15, 1-8, 2015 | 57 | 2015 |
| Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a … P Cahn, R Kaplan, PE Sax, K Squires, JM Molina, A Avihingsanon, ... The lancet HIV 4 (11), e486-e494, 2017 | 53 | 2017 |
| Renal impairment in HIV‐infected patients initiating tenofovir‐containing antiretroviral therapy regimens in a P rimary H ealthcare S etting in S outh A frica M Kamkuemah, R Kaplan, LG Bekker, F Little, L Myer Tropical Medicine & International Health 20 (4), 518-526, 2015 | 50 | 2015 |
| HIV prevalence and determinants of loss-to-follow-up in adolescents and young adults with tuberculosis in Cape Town P Mulongeni, S Hermans, J Caldwell, LG Bekker, R Wood, R Kaplan PLoS One 14 (2), e0210937, 2019 | 46 | 2019 |
